Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Alan Saven MD"'
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 4 (2016)
Ibrutinib (Imbruvica; Pharmacyclics) is the first Food and Drug Administration–approved inhibitor of Burton’s tyrosine kinase (BTK). Attenuation of BTK signaling ultimately leads to inhibition of B-cell proliferation and apoptosis. After a series
Externí odkaz:
https://doaj.org/article/45dd4a1eff2640f19d686e5ad6a43b01
